Clinical Metabolomics

Clinical metabolomics involves the application of clinical laboratory protocols, standards, and oversight of a global biochemical profiling technology whose results are interpreted relative to a reference adherent. The inevitable role of lipids in cell, tissue and organ physiology is explained by a large number of genetic studies and by many human diseases that involve the blockage of lipid metabolic enzymes and pathways. Examples of such diseases include diabetes, cancer as well as infectious diseases and neurodegenerative diseases. Within metabolomics, lipidomics has its own identity. Analytical approaches such as LC and MS for system-level analysis of lipids and their interacting partners now make this field a promising area of biomedical research, with a variety of applications in drug and biomarker development.

  • Translational biomarker discovery
  • Clinical applications of metabolomics
  • Metabolomics and mass spectrometry
  • Mass spec in Clinical Microbiology
  • Forensic analysis
  • Lipidomics

Related Conference of Clinical Metabolomics

April 16-17, 2020

16th World Congress on Structural Biology

Amsterdam, Netherlands
April 20-21, 2020

11th Tissue Science and Regeneration Congress

Kuala Lumpur, Malaysia
June 28-30 2020

globalbiotechnology-cs-2020

June 28-30 2020

oilgas-cs-2020

June 28-30 2020

BEHAVIOURAL SCIENCE-2020

June 28-30 2020

Bioinfo 2020

July 17-18, 2020

10th Glycobiology World Congress

Vienna, Austria
August 04,05 2020

12th Euro Biosensors & Bioelectronics Congress

Zurich, Switzerland
June 28-30 2020

NURSE PRACTITIONER 2020

September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
December 10-11, 2020

2nd European Pathology and Infectious Disease Conference

Abu Dhabi, UAE

Clinical Metabolomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in